Mendelian Randomization as a Tool for Cardiovascular Research: A Review

Area of Science:

• Cardiovascular Disease Research
• Genetic Epidemiology
• Statistical Genetics

Background:

• Mendelian randomization (MR) is increasingly vital for cardiovascular disease research, offering causal inference from observational data where clinical trials are unfeasible.
• MR leverages genetic variation, randomly assigned at conception, to act as proxies for modifiable risk factors, mitigating biases inherent in traditional observational studies.
• The growing availability of large genetic datasets makes MR a powerful and accessible tool for investigating cardiovascular disease etiology.

Purpose of the Study:

• To provide an overview of Mendelian randomization (MR) methodology in cardiovascular disease research.
• To highlight the strengths, limitations, and assumptions of MR.
• To showcase key applications of MR in understanding cardiovascular disease risk factors and identifying potential drug targets.

Main Methods:

• Utilizes genetic variants associated with risk factors as instrumental variables.
• Mimics randomized controlled trials by exploiting random genetic assortment at conception.
• Draws causal inferences by assessing the relationship between genetic variants, risk factors, and cardiovascular outcomes, while accounting for potential confounders.

Main Results:

• MR allows for the inference of potentially causal relationships between risk factors and cardiovascular outcomes.
• Identified limitations include weak instruments, linkage disequilibrium, overestimated associations, and selection/survival biases.
• A critical need exists for improved diversity in genetic databases and MR studies beyond European reference populations.

Conclusions:

• MR is a rigorous approach for investigating potential causal relationships in observational cardiovascular disease research.
• While not definitive proof, MR significantly enhances our understanding of disease etiology and treatment strategies.
• Emerging MR methodologies and applications continue to advance the field of cardiovascular research.